Synoviocyte stimulation by the LFA-1-intercellular adhesion molecule-2-Ezrin-Akt pathway in rheumatoid arthritis

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1971-1978

  Singh, Karnail ^a   Colmegna, Inés ^a   He, Xiaowen ^a   Weyand, Cornelia M ^a   Goronzy, Jörg J ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; EZRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN KINASE B; PROTEIN MDM2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; BLOCKING ANTIBODY; CELL ADHESION MOLECULE; CYTOSKELETON PROTEIN; ICAM2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ADULT; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CELL CULTURE; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; WESTERN BLOTTING; AGED; COCULTURE; CYTOLOGY; DRUG ANTAGONISM; FIBROBLAST; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; ANTIBODIES, BLOCKING; ANTIGENS, CD; ANTIGENS, CD11A; ARTHRITIS, RHEUMATOID; CELL ADHESION MOLECULES; COCULTURE TECHNIQUES; CYTOSKELETAL PROTEINS; FIBROBLASTS; HUMANS; INTERLEUKIN-6; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS;

EID: 40749138280     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1971     Document Type: Article

References (42)

1. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
2. Liu, H., P. Eksarko, V. Temkin, G. K. Haines, 3rd, H. Perlman, A. E. Koch, B. Thimmapaya, and R. M. Pope. 2005. Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis. J. Immunol. 175: 8337-8345.
3. Tak, P. P., N. J. Zvaifler, D. R. Green, and G. S. Firestein. 2000. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today 21: 78-82.
4. Franz, J. K., T. Pap, K. M. Hummel, M. Nawrath, W. K. Aicher, Y. Shigeyama, U. Muller-Ladner, R. E. Gay, and S. Gay. 2000. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 43: 599-607.
5. Pap, T., J. K. Franz, K. M. Hummel, E. Jeisy, R. Gay, and S. Gay. 2000. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2: 59-64.
6. Yamasaki, S., N. Yagishita, K. Nishioka, and T. Nakajima. 2007. The roles of synoviolin in crosstalk between endoplasmic reticulum stress-induced apoptosis and p53 pathway. Cell Cycle 6: 1319-1323.
7. Granet, C., W. Maslinski, and P. Miossec. 2004. Increased AP-1 and NF-κB activation and recruitment with the combination of the proinflammatory cytokines IL-1β, tumor necrosis factor α and IL-17 in rheumatoid synoviocytes. Arthritis Res. Ther. 6: R190-R198.
8. Krause, A., N. Scaletta, J. D. Ji, and L. B. Ivashkiv. 2002. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J. Immunol. 169: 6610-6616.
9. Lacey, D., A. Sampey, R. Mitchell, R. Bucala, L. Santos, M. Leech, and E. Morand. 2003. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 48: 103-109.
10. Sawai, H., Y. W. Park, X. He, J. J. Goronzy, and C. M. Weyand. 2007. Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum. 56: 3215-3225.
11. Lee, D. M., H. P. Kiener, S. K. Agarwal, E. H. Noss, G. F. Watts, O. Chisaka, M. Takeichi, and M. B. Brenner. 2007. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315: 1006-1010.
12. Valencia, X., J. M. Higgins, H. P. Kiener, D. M. Lee, T. A. Podrebarac, C. C. Dascher, G. F. Watts, E. Mizoguchi, B. Simmons, D. D. Patel, et al. 2004. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J. Exp. Med. 200: 1673-1679.
13. Tran, C. N., M. J. Davis, L. A. Tesmer, J. L. Endres, C. D. Motyl, C. Smuda, E. C. Somers, K. C. Chung, A. G. Urquhart, S. K. Lundy, et al. 2007. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum. 56: 1497-1506.
14. Yamamura, Y., R. Gupta, Y. Morita, X. He, R. Pai, J. Endres, A. Freiberg, K. Chung, and D. A. Fox. 2001. Effector function of resting T cells: activation of synovial fibroblasts. J. Immunol. 166: 2270-2275.
15. Goronzy, J. J., G. Henel, H. Sawai, K. Singh, E. B. Lee, S. Pryshchep, and C. M. Weyand. 2005. Costimulatory pathways in rheumatoid synovitis and T-cell senescence. Ann. NY Acad. Sci. 1062: 182-194.
16. Sawai, H., Y. W. Park, J. Roberson, T. Imai, J. J. Goronzy, and C. M. Weyand. 2005. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum. 52: 1392-1401.
17. + T cells. J. Exp. Med. 197: 437-449.
18. Vallejo, A. N., H. Yang, P. A. Klimiuk, C. M. Weyand, and J. J. Goronzy. 2003. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J. Immunol. 171: 1732-1740.
19. Groh, V., A. Bruhl, H. El-Gabalawy, J. L. Nelson, and T. Spies. 2003. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 100: 9452-9457.
20. Inoue, T., D. Hammaker, D. L. Boyle, and G. S. Firestein. 2005. Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J. Immunol. 174: 4301-4306.
21. Miagkov, A. V., D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov. 1998. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA 95: 13859-13864.
22. Morel, J., R. Audo, M. Hahne, and B. Combe. 2005. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 280: 15709-15718.
23. Sundarrajan, M., D. L. Boyle, M. Chabaud-Riou, D. Hammaker, and G. S. Firestein. 2003. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum. 48: 2450-2460.
24. Zhang, H. G., Y. Wang, J. F. Xie, X. Liang, D. Liu, P. Yang, H. C. Hsu, R. B. Ray, and J. D. Mountz. 2001. Regulation of tumor necrosis factor α-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum. 44: 1555-1567.
25. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13: 2905-2927.
26. null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165: 1138-1145.
27. Perez, O. D., S. Kinoshita, Y. Hitoshi, D. G. Payan, T. Kitamura, G. P. Nolan, and J. B. Lorens. 2002. Activation of the PKB/AKT pathway by ICAM-2. Immunity 16: 51-65.
28. Gautreau, A., P. Poullet, D. Louvard, and M. Arpin. 1999. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96: 7300-7305.
29. - T cells in rheumatoid arthritis. Mol. Med. 2: 608-618.
30. Goronzy, J. J., E. L. Matteson, J. W. Fulbright, K. J. Warrington, A. Chang-Miller, G. G. Hunder, T. G. Mason, A. M. Nelson, R. M. Valente, C. S. Crowson, et al. 2004. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 50: 43-54.
31. Pope, R. M. 2002. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev. Immunol. 2: 527-535.
32. Downward, J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10: 262-267.
33. Agarwal, S. K., and M. B. Brenner. 2006. Role of adhesion molecules in synovial inflammation. Curr. Opin. Rheumatol. 18: 268-276.
34. Oppenheimer-Marks, N., R. I. Brezinschek, M. Mohamadzadeh, R. Vita, and P. E. Lipsky. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J. Clin. Invest. 101: 1261-1272.
35. Nicolls, M. R., and R. G. Gill. 2006. LFA-1 (CD11a) as a therapeutic target. Am. J. Transplant. 6: 27-36.
36. Leonardi, C. L. 2003. Efalizumab: an overview. J. Am. Acad. Dermatol. 49: S98-S104.
37. Watts, G. M., F. J. Beurskens, I. Martin-Padura, C. M. Ballantyne, L. B. Klickstein, M. B. Brenner, and D. M. Lee. 2005. Manifestations of inflammatory arthritis are critically dependent on LFA-1. J. Immunol. 174: 3668-3675.
38. Wulfing, C., M. D. Sjaastad, and M. M. Davis. 1998. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc. Natl. Acad. Sci. USA 95: 6302-6307.
39. Tsai, C., L. A. Diaz, Jr., N. G. Singer, L. L. Li, A. H. Kirsch, R. Mitra, B. J. Nickoloff, L. J. Crofford, and D. A. Fox. 1996. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 39: 125-136.
40. Paniagua, R. T., O. Sharpe, P. P. Ho, S. M. Chan, A. Chang, J. P. Higgins, B. H. Tomooka, F. M. Thomas, J. J. Song, S. B. Goodman, et al. 2006. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J. Clin. Invest. 116: 2633-2642.
41. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97: 2027-2037.
42. Camps, M., T. Ruckle, H. Ji, V. Ardissone, F. Rintelen, J. Shaw, C. Ferrandi, C. Chabert, C. Gillieron, B. Francon, et al. 2005. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11: 936-943.